By GreatGameIndia – June 24, 2021
Norway has announced that you are at a greater risk of dying from AstraZeneca vaccine branded as Covishield in India than from COVID-19. While waiting for the final decision on the controversial vaccine, Norway has meanwhile decided to offload its stock of AstraZeneca to fellow Nordic countries that actually want to use them despite the associated risks.
Read more: Norway Says Risk Of Dying From AstraZeneca CoviShield Vaccine Higher Than Of COVID-19 — GreatGameIndia
By GreatGameIndia – June 13, 2021
Inflammation and swelling of the heart, a condition known as Myocarditis, has been identified in many youngsters who have received their dose of Pfizer-BioNTech COVID-19 vaccine. Although experts are still looking into the matter, the Centre for Disease Control and Prevention confirmed over 200 cases of myocarditis after COVID-19 vaccination in people 30 or below
Read more: How COVID-19 Vaccines Are Causing Myocarditis In Youngsters — GreatGameIndia
By GreatGameIndia – June 12, 2021
The European Medicines Agency’s (EMA) safety committee has added another blood condition to the potential side effects of AstraZeneca’s vaccine branded as Covishield in India – the Capillary Leak Syndrome.
Read more: Capillary Leak Syndrome – Another Side Effect Of AstraZeneca CoviShield Vaccine — GreatGameIndia